SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: celeryroot.com who wrote (29509)11/29/1999 6:20:00 PM
From: schadenfreude  Read Replies (1) | Respond to of 32384
 
>In addition, as a result of the positive findings from multiple pre-clinical studies, Ligand initiated in November 1998 a human Phase II clinical trial of Targretin capsules for the treatment of women with advanced breast cancer. Interim results are expected in the first half of 2000 from this ongoing clinical trial. <

I thought interim results were due by year-end?